BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 341650)

  • 1. [Double-blind trial of 2 antidepressive drugs].
    De León O; Kravcio JT; Sánchez C
    Acta Psiquiatr Psicol Am Lat; 1977 Sep; 23(3):215-20. PubMed ID: 341650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind comparison of viloxazine and amitryptyline in involutional and endogenous depression.
    Botter PA
    Acta Psychiatr Belg; 1979; 79(2):198-209. PubMed ID: 532690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy profile of viloxazine. Open clinical trial with 34 patients].
    Pérez de Francisco C
    Neurol Neurocir Psiquiatr; 1976; 17(2):115-21. PubMed ID: 1052716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synopsis of psychopathological, electroencephalographical, and pharmacokinetic variables during antidepressive treatment with viloxazine (author's transl)].
    Busch H; Bente D; Müller-Oerlinghausen B; Renfordt E
    Arzneimittelforschung; 1978; 28(8):1288-90. PubMed ID: 380579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
    Lennox IG; Asbury JF; Couldrick WG; Beswick KB
    Practitioner; 1978 Jan; 220(1315):153-6. PubMed ID: 343090
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
    Moizeszowicz J; Subirá S
    J Clin Pharmacol; 1977 Jan; 17(1):81-3. PubMed ID: 319120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
    Pöldinger W
    Dtsch Med Wochenschr; 1982 Apr; 107(17):661-5. PubMed ID: 7075479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile and serum concentration of viloxazine as compared to amitriptyline.
    Müller-Oerlinghausen B; Rüther E
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):321-37. PubMed ID: 386390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jun; 13(6):401-21. PubMed ID: 324751
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression.
    Kiloh LG; Bartrop RW; Franklin JA; Neilson MD
    Aust N Z J Psychiatry; 1979 Dec; 13(4):357-60. PubMed ID: 395939
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
    Santonastaso P; Maistrello I; Battistin L
    Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doubleblind study with the novel antidepressant viloxazine versus imipramine in 50 in-patients (author's transl)].
    Floru L; Czarny G; Tegeler J
    Arzneimittelforschung; 1976; 26(6):1170-1. PubMed ID: 786314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trials of viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Encephale; 1979; 5(3):243-9. PubMed ID: 385296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Viloxazine: its antidepressant action and lack of concomitant anticholinergic effect].
    Marchetti G; Amaducci L; Faravelli C; Matteini P; Pazzagli A
    Riv Patol Nerv Ment; 1977; 98(2):88-98. PubMed ID: 616014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viloxazine. Aspects of the therapeutic effect of the antidepressive agent viloxazine (Vivalan ICI) in the opinion of practicing neurologists].
    Jungkunz G
    MMW Munch Med Wochenschr; 1982 Aug; 124(32-33):712-4. PubMed ID: 6813688
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L
    Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.